Clinical Trial Update: Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating regadenoson as a pharmacologic stress agent for myocardial perfusion MRI in ischemic heart disease; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Ischemic Heart Disease | EARLY_Phase 1 | Status: COMPLETED